Literature DB >> 21324793

The role of iron in tumour cell proliferation.

Juan Luis Steegmann-Olmedillas1.   

Abstract

Iron has a pivotal role in homeostasis due to its participation in virtually all of the body's oxidation-reduction processes. However, iron can also be considered a double-edged weapon, as its excess may lead to an increased risk of developing cancer, presumably by the generation of reactive oxygen species, and its role as substrate to enzymes that participate in cell proliferation. Thus, iron might as well be considered a cofactor in tumour cell proliferation. In certain pathological conditions, such as haemochromatosis, hepatitis B and C virus infection, asbestosis and endometriosis, iron overload may increase the risk of cancer. By contrast, iron depletion could be considered a useful adjunct in antitumour therapy. This paper reviews the current scientific evidence behind iron's role as a protumoral agent, and the potential benefit of a state of iron depletion in patients with cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324793     DOI: 10.1007/s12094-011-0621-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  78 in total

Review 1.  The orchestration of body iron intake: how and where do enterocytes receive their cues?

Authors:  David M Frazer; Gregory J Anderson
Journal:  Blood Cells Mol Dis       Date:  2003 May-Jun       Impact factor: 3.039

2.  The new orally active iron chelator ICL670A exhibits a higher antiproliferative effect in human hepatocyte cultures than O-trensox.

Authors:  Karine Chantrel-Groussard; François Gaboriau; Nicole Pasdeloup; René Havouis; Hanspeter Nick; Jean-Louis Pierre; Pierre Brissot; Gérard Lescoat
Journal:  Eur J Pharmacol       Date:  2006-05-11       Impact factor: 4.432

3.  Comparative expression of major histocompatibility complex (MHC) antigens on CD5+ and CD5- B cells in patients with chronic lymphocytic leukaemia (CLL)

Authors:  A M Nouri; S Smith; T R Oliver; A C Newland; M G Macey
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

4.  Suggested models of ecotaxopathy in lymphoreticular malignancy. A role for iron-binding proteins in the control of lymphoid cell migration.

Authors:  M de Sousa; A Smithyman; C Tan
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

5.  Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.

Authors:  H Kawabata; R S Germain; P T Vuong; T Nakamaki; J W Said; H P Koeffler
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

6.  Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation, and differentiation of HL-60 cells.

Authors:  C Kaplinsky; Z Estrov; M H Freedman; E W Gelfand; A Cohen
Journal:  Leukemia       Date:  1987-05       Impact factor: 11.528

7.  Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.

Authors:  R Taetle; K Rhyner; J Castagnola; D To; J Mendelsohn
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism.

Authors:  G Lescoat; K Chantrel-Groussard; N Pasdeloup; H Nick; P Brissot; F Gaboriau
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

9.  Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments.

Authors:  Yves Lepelletier; Valérie Camara-Clayette; Hulin Jin; Aurélie Hermant; Séverine Coulon; Michaël Dussiot; Michelle Arcos-Fajardo; Cédric Baude; Danielle Canionni; Richard Delarue; Nicole Brousse; Philippe Benaroch; Marc Benhamou; Vincent Ribrag; Renato C Monteiro; Ivan C Moura; Olivier Hermine
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 10.  Linkage of cell-mediated immunity to iron metabolism.

Authors:  G Weiss; H Wachter; D Fuchs
Journal:  Immunol Today       Date:  1995-10
View more
  23 in total

1.  Oh the irony: Iron as a cancer cause or cure?

Authors:  Susan P Foy; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2011-10-01       Impact factor: 12.479

Review 2.  Regulation of cellular iron metabolism and its implications in lung cancer progression.

Authors:  Wei Xiong; Li Wang; Fenglei Yu
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

3.  Signs of deferasirox genotoxicity.

Authors:  Hasan Basri Ila; Mehmet Topaktas; Mehmet Arslan; Mehmet Büyükleyla
Journal:  Cytotechnology       Date:  2013-07-26       Impact factor: 2.058

4.  Inhalation of iron-abundant gas metal arc welding-mild steel fume promotes lung tumors in mice.

Authors:  L M Falcone; A Erdely; V Kodali; R Salmen; L A Battelli; T Dodd; W McKinney; S Stone; M Donlin; H D Leonard; J L Cumpston; J B Cumpston; R N Andrews; M L Kashon; J M Antonini; P C Zeidler-Erdely
Journal:  Toxicology       Date:  2018-07-25       Impact factor: 4.221

5.  Global miRNA/proteomic analyses identify miRNAs at 14q32 and 3p21, which contribute to features of chronic iron-exposed fallopian tube epithelial cells.

Authors:  Ravneet Chhabra; Stephanie Rockfield; Jennifer Guergues; Owen W Nadeau; Robert Hill; Stanley M Stevens; Meera Nanjundan
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

Review 6.  Harnessing microbial iron chelators to develop innovative therapeutic agents.

Authors:  Marta Ribeiro; Cátia A Sousa; Manuel Simões
Journal:  J Adv Res       Date:  2021-11-01       Impact factor: 12.822

Review 7.  Update on current and potential nanoparticle cancer therapies.

Authors:  Jonathan S Rink; Michael P Plebanek; Sushant Tripathy; C Shad Thaxton
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

8.  Markers of iron metabolism in retired racing Greyhounds with and without osteosarcoma.

Authors:  J T Caro; L M Marín; M C Iazbik; S Zaldivar-López; H Borghese; C G Couto
Journal:  Vet Clin Pathol       Date:  2013-09       Impact factor: 1.180

9.  An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration.

Authors:  Daniel Wysokinski; Malgorzata Zaras; Mariola Dorecka; Maja Waszczyk; Jerzy Szaflik; Janusz Blasiak; Jacek P Szaflik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-29       Impact factor: 3.117

10.  Neural and oligodendrocyte progenitor cells: transferrin effects on cell proliferation.

Authors:  Lucas Silvestroff; Paula Gabriela Franco; Juana María Pasquini
Journal:  ASN Neuro       Date:  2013-03-08       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.